InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Explore the full record of transactions filed by Apel Daniel Joseph, Chief Financial Officer. Insider active across 1 companies, notably Arrowhead Pharmaceuticals, INC.. In total, 2 disclosures have been published. Total volume traded: €384k. The latest transaction was disclosed on 22 April 2026 — Cession. Regulator: SEC (Form 4). All data is free.
Declarations2 total
US$192,1343,208 shares@ US$59.89220.0018% mcap100.0% of flow
Common Stock
SEC:0000879407-26-000039·
€192,1343,208 shares@ €59.89220.0018% mcap50.0% of flow
Common Stock
SEC:0000879407-26-000039:0·
2 of 2 declarations
About Apel Daniel Joseph
Daniel Joseph Apel is the Chief Financial Officer of ARROWHEAD PHARMACEUTICALS, INC. He oversees financial operations and contributes to the overall strategy of the company.
